SINGAPORE, Feb. 23, 2012 /CNW/ - Zecotek Photonics Inc. (TSX-V: ZMS) (Frankfurt: W1I), a developer of leading-edge photonics technologies for medical,
industrial and scientific markets, today announced that its subsidiary,
Zecotek Imaging Systems Pte Ltd., has started legal action in United
States Federal District Court in Los Angeles against defendants
Saint-Gobain Corporation and Philips for infringement of Zecotek's U.S.
Patent Number 7,132,060. Zecotek's patent covers the substances and
chemical formulations used to grow lutetium fine silicate (LFS)
scintillation crystals which are characterized by their combined high
light yield and ultra-fast decay times and are typically used in
medical scanning devices. The lawsuit alleges that Saint-Gobain's LYSO
crystals infringe Zecotek's patent, and that Philips infringes by using
those crystals in the PET scanners it sells.
"We believe that this patent is fundamental, and that damages are very
substantial," said Dr. A.F. Zerrouk, Chairman, President, and CEO of
Zecotek Photonics Inc. "Our management, engineers with its principal
scientists Drs. Alexander I. Zagumennyi and Yuri D. Zavartsev, world
leading crystal scientists and members of the Institute of the Russian
Academy of Sciences, have invested significant resources in the
development and commercialization of our LFS scintillation crystals,
including our ultra-fast Ce:Ca:LSO/LYSO scintillators. We have spent
many years of hard work to develop and secure this unique crystal
technology. We are determined to vigorously enforce our intellectual
property rights to recover damages afflicted on Zecotek and the lost
value to our shareholders".
U.S. Patent No. 7,132,060 covering Zecotek's LFS scintillation crystals
was granted on November 6, 2006.
Zecotek is joined by its exclusive licensee for certain LFS crystals,
Beijing Opto-Electronics Technology Co. Ltd., as co-plaintiff. Zecotek
is being represented by Thomas Loop of the law firm of Graybeal Jackson
LLP and Justin Nelson of Susman Godfrey LLP. Both firms are recognized
leaders in patent law and intellectual property litigation matters.
Zecotek Photonics Inc (TSX-V: ZMS; Frankfurt: W1I) is a photonics
technology company developing high-performance crystals, photo
detectors, medical lasers, optical imaging and 3D display technologies
for commercial applications in the medical diagnostics and high-tech
industry. Founded in 2003, the company has three distinct operating
divisions: medical imaging, medical lasers and 3D display and labs
located in Canada, Singapore and Russia. Zecotek commercializes its
novel, patented and patent-pending bio-photonic technologies directly
and through strategic alliances and joint ventures with multinational
OEMs, distributors and other industry leaders. For more information,
please visit www.zecotek.com.
This press release may contain forward-looking statements that are based
on management's expectations, estimates, projections and assumptions.
These statements are not guarantees of future performance and involve
certain risks and uncertainties, which are difficult to predict.
Therefore, actual future results and trends may differ materially from
what may have been stated.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as
that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of the content of
this news release. If you would like to receive news from Zecotek in
the future please visit the corporate website at www.zecotek.com.
SOURCE Zecotek Medical Systems Inc.
For further information:
Zecotek Photonics Inc.
T: (604) 783-8291
CHF Investor Relations
Julia Clark, Account Manager
T: (416) 868-1079 x236